Strekin

About:

Strekin AG is a clinical-stage biopharmaceutical company headquartered in Basel, Switzerland.

Description:

Strekin AG is a clinical-stage biopharmaceutical company headquartered in Basel, Switzerland. Strekin was founded in 2014 by Dr. Alexander Bausch, Prof. Dr. Daniel Bodmer, and Mr. Roger Meier.

Total Funding Amount:

12.8M CHF

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Basel, Basel-Stadt, Switzerland

Founded Date:

2014-01-01

Contact Email:

Info(AT)strekin.Com

Founders:

Alexander Bausch

Number of Employees:

11-50

Last Funding Date:

2019-09-03

IPO Status:

Private

Industries: